Sutton Wealth Advisors Inc. Cara Therapeutics, Inc. Transaction History

Sutton Wealth Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$4.89 - $12.27 $3,599 - $9,030	-736 Closed	0 $0
Q3 2022 Nov 07, 2023	BUY	$8.24 - $12.56 $5,792 - $8,829	703 Added 2130.3%	736 $6.89 Million
Q2 2022 Nov 07, 2023	SELL	$7.45 - $13.84 $7,859 - $14,601	-1,055 Reduced 96.97%	33 $301,000
Q1 2022 Nov 07, 2023	BUY	$9.94 - $12.65 $4,482 - $5,705	451 Added 70.8%	1,088 $13.2 Million
Q4 2021 Nov 07, 2023	BUY	$11.99 - $18.14 $347 - $526	29 Added 4.77%	637 $7.76 Million
Q3 2021 Nov 07, 2023	BUY	$11.55 - $16.06 $150 - $208	13 Added 2.18%	608 $9.39 Million
Q2 2021 Nov 07, 2023	BUY	$12.38 - $29.19 $7,366 - $17,368	595 New	595 $8.49 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $288M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.